Filing Details
- Accession Number:
- 0001209191-10-011803
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2010-02-24 12:00:00
- Reporting Period:
- 2009-05-18
- Filing Date:
- 2010-02-24
- Accepted Time:
- 2010-02-24 16:57:04
- Original Submission Date:
- 2010-02-19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899460 | Mannkind Corp | MNKD | Pharmaceutical Preparations (2834) | 133607736 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1192063 | J Matthew Pfeffer | 28903 North Avenue Paine Valencia CA 91355 | Corporate Vp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value | Acquisiton | 2010-02-17 | 6,300 | $2.86 | 35,157 | No | 4 | M | Direct | |
Common Stock, $.01 Par Value | Disposition | 2010-02-17 | 6,300 | $10.00 | 28,857 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value | Employee Stock Option | Acquisiton | 2009-05-18 | 24,000 | $2.86 | 24,000 | $2.86 |
Common Stock, $.01 Par Value | Employee Stock Option | Disposition | 2010-02-17 | 6,300 | $0.00 | 6,300 | $2.86 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,000 | 2009-05-18 | 2018-04-28 | No | 4 | A | Direct |
17,700 | 2009-05-18 | 2018-04-28 | No | 4 | M | Direct |
Footnotes
- This report is being filed to correct the exercise price of the previously reported performance option. This report reflects the exercise price when the milestone was met.
- Transaction occurred pursuant to Rule 10B5-1 Plan.